Novocure (NASDAQ: NVCR) in the present day introduced the appointment of Frank Leonard as Chief Executive Officer (CEO), efficient instantly. Mr. Leonard beforehand served as President of Novocure and succeeds Ashley Cordova who has resigned from the corporate. “During his greater than 15-year profession at Novocure, Frank has led lots of our world enterprise operations…
WCG, a world chief in offering options that measurably enhance and speed up medical analysis, right now introduced the discharge of the WCG CenterWatch 2025 AI Benchmarking Report. Available now on the brand new WCG CenterWatch Research Hub, this report delivers unique insights into how synthetic intelligence is shaping medical trial operations, accelerating improvement timelines, and advancing…
MRO declares the acquisition of Clinetic, a number one recruitment administration platform designed to assist healthcare organizations and life sciences corporations discover, display screen and enroll sufferers for medical trials with larger velocity and precision. The addition of Clinetic’s AI-driven software program and experience marks one other step ahead in MRO’s dedication to being the single…
Investment by Avego will prolong attain, speed up AI innovation, and deepen trade partnerships. myTomorrows, a well being expertise firm that connects sufferers with all attainable pre-approval therapies, right now introduced the shut of a $29 million financing with Avego. Avego’s progress fairness funding will gas the worldwide enlargement of myTomorrows’ built-in pharma options to…
Sitero, a technology-enabled Clinical Research Organization (CRO), at this time introduced it has acquired the AI belongings and enterprise of studyOS – a novel eClinical AI know-how supplier and creator of Ash – the AI Clinical Trial Agent. The transaction marks one other milestone in Sitero’s mission to deeply combine superior know-how with operational excellence…
Together we’re unlocking the true potential of scientific trial lab knowledge, bringing sooner insights, smarter selections, and higher outcomes. LabConnect, a number one world supplier of central laboratory providers immediately introduced plans to type a strategic collaboration with OmniScience, the AI firm behind Vivo, the primary agentic AI management tower for scientific trials. Together, they’ll ship…
HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical trials are designed and executed. At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, HopeAI presented new results demonstrating how AI-generated synthetic individual patient data ( SynthIPD ) can accelerate regulatory-grade evidence generation — without the need for real patient-level…
Apriori to leverage foundational insights from the Crick’s Legacy Study to further validate Octavia platform’s ability to predict viral evolution and vaccine performance Apriori Bio, a biotechnology company focused on developing variant-resilient vaccines, today announced a research collaboration with the Francis Crick Institute to better understand critical aspects of immune response, with the goal of informing…
Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations of cancer patient populations that remain difficult to treat and study in laboratory settings. To develop novel treatments for patients, scientists must first understand the biological…
In direct support of the White House and CMS’s bold initiative to “Make Health Tech Great Again,” Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology. With its Patient Connect app and intelligent assistant DrArturoAI already live and serving patients,…